This week's guests:
James Choi
James Choi is the Principal Investigator of Non-invasive Surgery and Biopsy Laboratory at Imperial College London and is an Associate Professor in the Department of Bioengineering at the institute. The purpose of the Noninvasive Surgery & Biopsy Laboratory is to build incision-less microsurgical devices and methods to locally deliver drugs to the brain. James Choi is a leading expert on the blood brain barrier and has authored numerous research publications in the fields of noninvasive surgery and delivery through the blood brain barrier using focused ultrasound. James Choi’s work at the laboratory is currently focused on treating several diseases, including Alzheimers, using non-invasive devices for delivering drugs across the blood-brain barrier.
Sam Barker
Sam Barker is the Chief Business Officer at Somaserve, a genetic medicines company that is pioneering new medicines for crossing the blood brain barrier and other biological barriers. Using a proprietary targeted polymer nanoparticle technology, PolyNaut®, Somaserve is delivering genetic materials to cells and tissues of choice, including targeted delivery to the central nervous system. Sam Barker has deep experience in start-up and growth stage companies across drug development from discovery to delivery, with expertise in developing and commercialising innovative platform technologies.
.jpg)
